TrianglePUBLICATIONS · 22381410
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Nucl Med
- Publication date
- 2012 Apr
- First author
- Van den Abbeele AD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Van den Abbeele AD
- type
- Author
- name
- Gatsonis C
- type
- Author
- name
- de Vries DJ
- type
- Author
- name
- Melenevsky Y
- type
- Author
- name
- Szot-Barnes A
- type
- Author
- name
- Yap JT
- type
- Author
- name
- Godwin AK
- type
- Author
- name
- Rink L
- type
- Author
- name
- Huang M
- type
- Author
- name
- Blevins M
- type
- Author
- name
- Sicks J
- type
- Author
- name
- Eisenberg B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Van den Abbeele AD
- type
- Author
- name
- Gatsonis C
- type
- Author
- name
- de Vries DJ
- type
- Author
- name
- Melenevsky Y
- type
- Author
- name
- Szot-Barnes A
- type
- Author
- name
- Yap JT
- type
- Author
- name
- Godwin AK
- type
- Author
- name
- Rink L
- type
- Author
- name
- Huang M
- type
- Author
- name
- Blevins M
- type
- Author
- name
- Sicks J
- type
- Author
- name
- Eisenberg B
- type
- Author
- bibliography ids
- nci-bib-2bc5258339c8e3307744e76d
- book metadata
- content sha256
- 3e535e9d6861f1f2cdcc1686f30af3c840c00718566649e8d1944a7654022129
- document type
- citation
- dois
- 10.2967/jnumed.111.094425
- electronic publication date
- display
- 2012 Mar 1
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22381410
- immutable id
- pubmed:22381410@3e535e9d6861f1f2cdcc1686f30af3c840c00718566649e8d1944a7654022129
- journal
- abbreviation
- J Nucl Med
- issn electronic
- 1535-5667
- issn print
- 0161-5505
- issue
- 4
- name
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- nlm unique id
- 0217410
- pages
- 567-74
- volume
- 53
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22381410
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- 229035e1170a51c4b19c2a9e3f8586d2b54da8c834a4e627b75a95f0ef1d0686
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Apr
- precision
- month
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
Preserved source evidence · Not medical advice